Literature DB >> 24929969

APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years.

Joy L Taylor1, Blake K Scanlon2, Michelle Farrell2, Beatriz Hernandez2, Maheen M Adamson2, J Wesson Ashford2, Art Noda2, Greer M Murphy3, Michael W Weiner4.   

Abstract

Atrophy of the hippocampus and surrounding temporal regions occurs in Alzheimer's disease (AD). APOE ε4, the major genetic risk factor for late-onset AD, has been associated with smaller volume in these regions before amyloidosis can be detected by AD biomarkers. To examine APOE ε4 effects in relation to aging, we performed a longitudinal magnetic resonance imaging study involving cognitively normal adults (25 APOE ε4 carriers and 31 ε3 homozygotes), initially aged 51-75 years. We used growth curve analyses, which can provide information about APOE ε4-related differences initially and later in life. Hippocampal volume was the primary outcome; nearby medial temporal regions were secondary outcomes. Brain-derived neurotrophic factor, val66met was a secondary covariate. APOE ε4 carriers had significantly smaller initial hippocampal volumes than ε3 homozygotes. Rate of hippocampal atrophy was not greater in the APOE ε4 group, although age-related atrophy was detected in the overall sample. The findings add to the growing evidence that effects of APOE ε4 on hippocampal size begin early in life, underscoring the importance of early interventions to increase reserve.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Alzheimer's disease; Apolipoprotein E4; Brain-derived neurotrophic factor; Hippocampus; Longitudinal studies; Magnetic resonance imaging

Mesh:

Substances:

Year:  2014        PMID: 24929969      PMCID: PMC4171437          DOI: 10.1016/j.neurobiolaging.2014.05.011

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  59 in total

1.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-11-08       Impact factor: 6.556

2.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Authors:  David A Wolk; Bradford C Dickerson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

3.  Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs.

Authors:  B Richards; J Skoletsky; A P Shuber; R Balfour; R C Stern; H L Dorkin; R B Parad; D Witt; K W Klinger
Journal:  Hum Mol Genet       Date:  1993-02       Impact factor: 6.150

4.  Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve.

Authors:  Larry A Tupler; K Ranga R Krishnan; Daniel L Greenberg; Santica M Marcovina; Martha E Payne; James R MacFall; H Cecil Charles; P Murali Doraiswamy
Journal:  Neurobiol Aging       Date:  2006-08-17       Impact factor: 4.673

5.  Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.

Authors:  Robert M Koffie; Tadafumi Hashimoto; Hwan-Ching Tai; Kevin R Kay; Alberto Serrano-Pozo; Daniel Joyner; Steven Hou; Katherine J Kopeikina; Matthew P Frosch; Virginia M Lee; David M Holtzman; Bradley T Hyman; Tara L Spires-Jones
Journal:  Brain       Date:  2012-05-26       Impact factor: 13.501

Review 6.  Modifiable factors that alter the size of the hippocampus with ageing.

Authors:  Majid Fotuhi; David Do; Clifford Jack
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

7.  Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.

Authors:  Johanna Lind; Anne Larsson; Jonas Persson; Martin Ingvar; Lars-Göran Nilsson; Lars Bäckman; Rolf Adolfsson; Marc Cruts; Kristel Sleegers; Christine Van Broeckhoven; Lars Nyberg
Journal:  Neurosci Lett       Date:  2006-01-06       Impact factor: 3.046

8.  Hippocampal plasticity in response to exercise in schizophrenia.

Authors:  Frank-Gerald Pajonk; Thomas Wobrock; Oliver Gruber; Harald Scherk; Dorothea Berner; Inge Kaizl; Astrid Kierer; Stephanie Müller; Martin Oest; Tim Meyer; Martin Backens; Thomas Schneider-Axmann; Allen E Thornton; William G Honer; Peter Falkai
Journal:  Arch Gen Psychiatry       Date:  2010-02

9.  Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia.

Authors:  Yuan-Yu Hsu; Norbert Schuff; An-Tao Du; Kevin Mark; Xiaoping Zhu; Dawn Hardin; Michael W Weiner
Journal:  J Magn Reson Imaging       Date:  2002-09       Impact factor: 4.813

10.  Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots.

Authors:  Maheen M Adamson; Kelly M Landy; Susan Duong; Sabrina Fox-Bosetti; J Wesson Ashford; Greer M Murphy; Michael Weiner; Joy L Taylor
Journal:  Neurobiol Aging       Date:  2008-08-29       Impact factor: 4.673

View more
  13 in total

Review 1.  Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.

Authors:  Marine Fouquet; Florent L Besson; Julie Gonneaud; Renaud La Joie; Gaël Chételat
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

Review 2.  Structural imaging measures of brain aging.

Authors:  Samuel N Lockhart; Charles DeCarli
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

3.  Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype.

Authors:  Shruti Mishra; Tyler M Blazey; David M Holtzman; Carlos Cruchaga; Yi Su; John C Morris; Tammie L S Benzinger; Brian A Gordon
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

4.  Neuroimaging genetic risk for Alzheimer's disease in preclinical individuals: From candidate genes to polygenic approaches.

Authors:  Theresa M Harrison; Susan Y Bookheimer
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-01-01

5.  Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.

Authors:  Katherine Reiter; Kristy A Nielson; Sally Durgerian; John L Woodard; J Carson Smith; Michael Seidenberg; Dana A Kelly; Stephen M Rao
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  APOE ε4 associated with preserved executive function performance and maintenance of temporal and cingulate brain volumes in younger adults.

Authors:  Warren D Taylor; Brian Boyd; Rachel Turner; Douglas R McQuoid; Allison Ashley-Koch; James R MacFall; Ayman Saleh; Guy G Potter
Journal:  Brain Imaging Behav       Date:  2017-02       Impact factor: 3.978

7.  Estimating anatomical trajectories with Bayesian mixed-effects modeling.

Authors:  G Ziegler; W D Penny; G R Ridgway; S Ourselin; K J Friston
Journal:  Neuroimage       Date:  2015-07-17       Impact factor: 6.556

8.  Adaptive lymphocyte profiles correlate to brain Aβ burden in patients with mild cognitive impairment.

Authors:  Ann M Stowe; Sara J Ireland; Sterling B Ortega; Ding Chen; Ryan M Huebinger; Takashi Tarumi; Thomas S Harris; C Munro Cullum; Roger Rosenberg; Nancy L Monson; Rong Zhang
Journal:  J Neuroinflammation       Date:  2017-07-27       Impact factor: 8.322

9.  Cognitive complaints are associated with smaller right medial temporal gray-matter volume in younger postmenopausal women.

Authors:  Alexander C Conley; Kimberly M Albert; Brian D Boyd; Shin-Gyeom Kim; Sepideh Shokouhi; Brenna C McDonald; Andrew J Saykin; Julie A Dumas; Paul A Newhouse
Journal:  Menopause       Date:  2020-11       Impact factor: 3.310

10.  Age-Modulated Associations between KIBRA, Brain Volume, and Verbal Memory among Healthy Older Adults.

Authors:  Ariana Stickel; Kevin Kawa; Katrin Walther; Elizabeth Glisky; Ryan Richholt; Matt Huentelman; Lee Ryan
Journal:  Front Aging Neurosci       Date:  2018-01-10       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.